Sobetirome: Targeting Fat Metabolism and Neurological Disorders

Sobetirome, a synthetic thyroid hormone analog, selectively targets thyroid hormone receptor beta (TRβ) to offer therapeutic benefits in conditions like hypercholesterolemia without usual side effects. By sparing the alpha-receptors linked to cardiac concerns, sobetirome shows promise in lowering cholesterol and improving metabolic rates safely. Research continues to explore its efficacy and safety, aiming to leverage thyroid hormone benefits with reduced risks, highlighting its potential in treating lipid and neurological disorders.

Sanofi Breaks New Ground: Innovations in Vaccine Development

Sanofi is a global biopharmaceutical leader headquartered in Paris, known for healthcare innovation. With a diverse portfolio including prescription medicines and vaccines, Sanofi enhances patient quality of life worldwide. The company prioritizes research, investing in treatments for oncology, rare diseases, and more. Committed to sustainability, Sanofi partners globally to ensure access to essential healthcare solutions.

Select Wishlist

    Left Menu Icon
    Your Cart